NCT03886948View on ClinicalTrials.gov

A Study of Injections of LY3074828 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

March 27, 2019

Primary Completion Date

October 4, 2019

Study Completion Date

October 4, 2019

Conditions
Healthy
Interventions
DRUG

LY3074828

Administered subcutaneously (SC)

DEVICE

Pre-filled syringe (PFS)

PFS used to administer LY3074828

DEVICE

Autoinjector (AI)

AI used to administer LY3074828

Trial Locations (1)

32117

Covance Clinical Research Inc, Daytona Beach

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03886948 - A Study of Injections of LY3074828 in Healthy Participants | Biotech Hunter | Biotech Hunter